293 related articles for article (PubMed ID: 6975439)
21. High-dose methotrexate in osteogenic sarcoma.
Jaffe N; Link MP; Cohen D; Traggis D; Frei E; Watts H; Beardsley GP; Abelson HT
Natl Cancer Inst Monogr; 1981 Apr; (56):201-6. PubMed ID: 6975438
[TBL] [Abstract][Full Text] [Related]
22. [Surgery and adjuvant chemotherapy of osteosarcoma].
Yamawaki S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1576-83. PubMed ID: 3460527
[TBL] [Abstract][Full Text] [Related]
23. [Combination chemotherapy in osteogenic sarcoma: the Memorial Sloan-Kettering cancer center experience (author's transl)].
Jürgens H; Rosen G
Klin Padiatr; 1980 Mar; 192(2):123-9. PubMed ID: 6158596
[TBL] [Abstract][Full Text] [Related]
24. [The results of using high-dose methotrexate in treating osteogenic sarcoma].
Perevodchikova NI; Eremina LA; Manziuk LV; Siniukov PA; Fedenko AN; Singin AS; Moldovanova LK
Vopr Onkol; 1990; 36(6):667-71. PubMed ID: 2378085
[TBL] [Abstract][Full Text] [Related]
25. No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcoma.
Bacci G; Loro L; Longhi A; Bertoni F; Bacchini P; Versari M; Picci P; Serra M
Anticancer Drugs; 2006 Apr; 17(4):411-5. PubMed ID: 16549998
[TBL] [Abstract][Full Text] [Related]
26. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
Rosen G; Marcove RC; Caparros B; Nirenberg A; Kosloff C; Huvos AG
Cancer; 1979 Jun; 43(6):2163-77. PubMed ID: 88251
[TBL] [Abstract][Full Text] [Related]
27. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
[TBL] [Abstract][Full Text] [Related]
28. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.
Tsuchiya H; Tomita K; Mori Y; Asada N; Morinaga T; Kitano S; Yamamoto N
Anticancer Res; 1998; 18(1B):657-66. PubMed ID: 9584049
[TBL] [Abstract][Full Text] [Related]
29. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
Goorin AM; Schwartzentruber DJ; Devidas M; Gebhardt MC; Ayala AG; Harris MB; Helman LJ; Grier HE; Link MP;
J Clin Oncol; 2003 Apr; 21(8):1574-80. PubMed ID: 12697883
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate levels and outcome in osteosarcoma.
Zelcer S; Kellick M; Wexler LH; Shi W; Sankaran M; Lo S; Healey J; Huvos AG; Meyers PA; Gorlick R
Pediatr Blood Cancer; 2005 Jun; 44(7):638-42. PubMed ID: 15704189
[TBL] [Abstract][Full Text] [Related]
31. [The Zurich experience with preoperative high-dose methotrexate in osteosarcomas].
Honegger HP; Cserhati MD; von Hochstetter A; Hofmann V; Groscurth P
Schweiz Med Wochenschr; 1983 May; 113(18):663-71. PubMed ID: 6575441
[TBL] [Abstract][Full Text] [Related]
32. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
[TBL] [Abstract][Full Text] [Related]
33. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
Hawkins DS; Arndt CA
Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080
[TBL] [Abstract][Full Text] [Related]
34. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
Graf N; Jost W; Müller J; Keller HE; Sitzmann FC
Klin Padiatr; 1990; 202(5):340-6. PubMed ID: 2214594
[TBL] [Abstract][Full Text] [Related]
35. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
36. Combination chemotherapy for osteosarcoma.
Pratt CB; Rivera G; Shanks E; Kumar AP; Green AA; George S
Cancer Treat Rep; 1978 Feb; 62(2):251-7. PubMed ID: 346214
[TBL] [Abstract][Full Text] [Related]
37. [The importance of dose intensity in preoperative chemotherapy for osteosarcoma--retrospective analysis of a short intensive chemotherapy regimen preoperatively using high-dose methotrexate and cisplatinum].
Takahashi M; Katagiri H; Sato K; Sugiura H; Yamamura S; Fukaya N; Nakanishi K
Gan To Kagaku Ryoho; 1994 Mar; 21(4):459-64. PubMed ID: 8129386
[TBL] [Abstract][Full Text] [Related]
38. High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma.
Cotter SM; Parker LM
Am J Vet Res; 1978 Dec; 39(12):1943-5. PubMed ID: 312044
[TBL] [Abstract][Full Text] [Related]
39. Metastatic osteosarcoma.
Daw NC; Billups CA; Rodriguez-Galindo C; McCarville MB; Rao BN; Cain AM; Jenkins JJ; Neel MD; Meyer WH
Cancer; 2006 Jan; 106(2):403-12. PubMed ID: 16353204
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
